A Phase 1 Study of Ipilimumab in Combination With Decitabine in Relapsed or Refractory Myelodysplastic Syndrome/Acute Myeloid Leukemia
Phase of Trial: Phase I
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Decitabine (Primary) ; Ipilimumab (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions
- 24 May 2017 Planned End Date changed from 1 Nov 2019 to 1 Sep 2018.
- 24 May 2017 Planned primary completion date changed from 1 Nov 2019 to 1 Sep 2018.
- 24 May 2017 Status changed from not yet recruiting to recruiting.